Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 173

Results For "innovative"

1780 News Found

Labcorp, a leader in women’s heath solutions acquires Ovia Health
Digitisation | August 13, 2021

Labcorp, a leader in women’s heath solutions acquires Ovia Health

The transaction improves patient experience, patient outcomes and aims to reduce health care costs


Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
Drug Approval | August 12, 2021

Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee

The company is eligible for 12 months exclusivity from launch


QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater
Drug Approval | August 11, 2021

QIAGEN and GT Molecular collaborate to detect SARS-CoV-2 in wastewater

Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases


FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer
Digitisation | August 11, 2021

FUJIFILM Irvine Scientific appointed global distributor of Presagen’s Life Whisperer

High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection


Moderna to set up mRNA manufacturing in Canada
Biotech | August 11, 2021

Moderna to set up mRNA manufacturing in Canada

The collaboration will support Canada with direct access to rapid pandemic response capabilities


Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
Digitisation | August 11, 2021

Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx

OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.


Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China
Biotech | August 11, 2021

Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China

The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial


Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
Biotech | August 10, 2021

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments


Atara Biotherapeutics, Pascal Touchon, Ameet Mallik, Rafael Holdings
Biotech | August 10, 2021

Atara Biotherapeutics, Pascal Touchon, Ameet Mallik, Rafael Holdings

A veteran in cell therapy and oncology commercialisation


QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements
Drug Approval | August 10, 2021

QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements

QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab